Literature DB >> 30610846

Toxicity tests of cryoprotecting agents for Mytilus galloprovincialis (Lamark, 1819) early developmental stages.

P Heres1, R Rodriguez-Riveiro2, J Troncoso1, E Paredes3.   

Abstract

Global aquaculture production of blue mussel has increased over last years. This work reaffirms the great potential of cryopreservation technique on mussel industry and overcome economic barriers a cause of a traditional and rudimentary management and continue growing. The aim of this work is to set some preliminary basis attending to toxicity of cryoprotecting agents (CPAs) on different development stages of Mytilus galloprovincialis as a start point to develop a stable cryopreservation protocol. Toxicity tests were carried out by using common CPAs (dimethyl-sulfoxide (Me2SO), glycerol, (GLY), propylene glycol (PG) and ethylene glycol (EG)) in a range from 0.5 to 3 M on fertilized egg, trochophore larva, and D-larva of Mytilus galloprovincialis. Results evidenced more resistance of older development stages to toxicity. Of all CPAs tested, toxicity testing highlights PG or EG as suitable CPAs for cryopreservation of early development stages; whereas D-larva was unaffected by any of the CPAs tested. Preliminary cryopreservation trials were developed to obtain information into cell cryoprotection. Further research should be focused on membrane permeability and other parameters, such as the balance between toxicity and cryoprotective effect of CPAs.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cryopreservation; Cryoprotecting agents; Marine invertebrates; Mussel; Toxicity

Year:  2019        PMID: 30610846     DOI: 10.1016/j.cryobiol.2019.01.001

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  1 in total

1.  Long-term study on survival and development of successive generations of Mytilus galloprovincialis cryopreserved larvae.

Authors:  P Heres; J Troncoso; E Paredes
Journal:  Sci Rep       Date:  2022-08-10       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.